Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel κ-opioid receptor agonist nalfurafine hydrochloride

Hideo Umeuchi, Yumi Kawashima, Christopher A. Aoki, Takahiro Kurokawa, Kaoru Nakao, Masatoshi Itoh, Kentaro Kikuchi, Takashi Kato, Kiyoshi Okano, M. Eric Gershwin, Hiroshi Miyakawa

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Pruritus is a common, distressing and difficult to manage complication of many autoimmune diseases. A suitable animal model of autoimmune disease associated pruritus would contribute to a better understanding of the pathophysiology of this symptom and lead to the development of safe and effective antipruritic agents. We noticed spontaneous scratching behavior in aged MRL/lpr mice, a model of autoimmune disease. This scratching behavior was observed in a specific pathogen-free environment and was more frequent in female mice. In contrast to animal models of dermatitis; NC/Nga mice, the serum IgE and IgG1 levels in MRL/lpr mice were not elevated. These features indicate that this scratching behavior is similar to human autoimmune disease associated pruritus. The antipruritic effects of an antihistamine (chlorpheniramine), an opioid receptor antagonist (naltrexone), and a novel κ-opioid receptor agonist (nalfurafine hydrochloride [TRK-820]) were evaluated. The frequency of scratching was not reduced by oral administration of chlorpheniramine, suggesting that the behavior is antihistamine-resistant. The oral administration of nalfurafine and subcutaneously administered naltrexone inhibited the scratching behavior without causing gross behavioral changes. In conclusion, MRL/lpr mice scratching behavior is a suitable model of pruritus that occurs in autoimmune diseases, and nalfurafine was shown to be efficacious against this behavior suggesting that it may be beneficial in patients with autoimmune disease associated pruritus.

Original languageEnglish (US)
Pages (from-to)133-139
Number of pages7
JournalEuropean Journal of Pharmacology
Volume518
Issue number2-3
DOIs
StatePublished - Aug 22 2005
Externally publishedYes

Fingerprint

Antipruritics
Inbred MRL lpr Mouse
Opioid Receptors
Pruritus
Autoimmune Diseases
Chlorpheniramine
Naltrexone
Histamine Antagonists
Oral Administration
Animal Models
Specific Pathogen-Free Organisms
Narcotic Antagonists
Dermatitis
TRK 820
Immunoglobulin E
Immunoglobulin G

Keywords

  • κ-opioid agonist
  • MRL/lpr mouse
  • Pruritus
  • Scratching behavior

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel κ-opioid receptor agonist nalfurafine hydrochloride. / Umeuchi, Hideo; Kawashima, Yumi; Aoki, Christopher A.; Kurokawa, Takahiro; Nakao, Kaoru; Itoh, Masatoshi; Kikuchi, Kentaro; Kato, Takashi; Okano, Kiyoshi; Gershwin, M. Eric; Miyakawa, Hiroshi.

In: European Journal of Pharmacology, Vol. 518, No. 2-3, 22.08.2005, p. 133-139.

Research output: Contribution to journalArticle

Umeuchi, Hideo ; Kawashima, Yumi ; Aoki, Christopher A. ; Kurokawa, Takahiro ; Nakao, Kaoru ; Itoh, Masatoshi ; Kikuchi, Kentaro ; Kato, Takashi ; Okano, Kiyoshi ; Gershwin, M. Eric ; Miyakawa, Hiroshi. / Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel κ-opioid receptor agonist nalfurafine hydrochloride. In: European Journal of Pharmacology. 2005 ; Vol. 518, No. 2-3. pp. 133-139.
@article{be6c6a04fe144ee48abd5438215f68fd,
title = "Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel κ-opioid receptor agonist nalfurafine hydrochloride",
abstract = "Pruritus is a common, distressing and difficult to manage complication of many autoimmune diseases. A suitable animal model of autoimmune disease associated pruritus would contribute to a better understanding of the pathophysiology of this symptom and lead to the development of safe and effective antipruritic agents. We noticed spontaneous scratching behavior in aged MRL/lpr mice, a model of autoimmune disease. This scratching behavior was observed in a specific pathogen-free environment and was more frequent in female mice. In contrast to animal models of dermatitis; NC/Nga mice, the serum IgE and IgG1 levels in MRL/lpr mice were not elevated. These features indicate that this scratching behavior is similar to human autoimmune disease associated pruritus. The antipruritic effects of an antihistamine (chlorpheniramine), an opioid receptor antagonist (naltrexone), and a novel κ-opioid receptor agonist (nalfurafine hydrochloride [TRK-820]) were evaluated. The frequency of scratching was not reduced by oral administration of chlorpheniramine, suggesting that the behavior is antihistamine-resistant. The oral administration of nalfurafine and subcutaneously administered naltrexone inhibited the scratching behavior without causing gross behavioral changes. In conclusion, MRL/lpr mice scratching behavior is a suitable model of pruritus that occurs in autoimmune diseases, and nalfurafine was shown to be efficacious against this behavior suggesting that it may be beneficial in patients with autoimmune disease associated pruritus.",
keywords = "κ-opioid agonist, MRL/lpr mouse, Pruritus, Scratching behavior",
author = "Hideo Umeuchi and Yumi Kawashima and Aoki, {Christopher A.} and Takahiro Kurokawa and Kaoru Nakao and Masatoshi Itoh and Kentaro Kikuchi and Takashi Kato and Kiyoshi Okano and Gershwin, {M. Eric} and Hiroshi Miyakawa",
year = "2005",
month = "8",
day = "22",
doi = "10.1016/j.ejphar.2005.06.019",
language = "English (US)",
volume = "518",
pages = "133--139",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel κ-opioid receptor agonist nalfurafine hydrochloride

AU - Umeuchi, Hideo

AU - Kawashima, Yumi

AU - Aoki, Christopher A.

AU - Kurokawa, Takahiro

AU - Nakao, Kaoru

AU - Itoh, Masatoshi

AU - Kikuchi, Kentaro

AU - Kato, Takashi

AU - Okano, Kiyoshi

AU - Gershwin, M. Eric

AU - Miyakawa, Hiroshi

PY - 2005/8/22

Y1 - 2005/8/22

N2 - Pruritus is a common, distressing and difficult to manage complication of many autoimmune diseases. A suitable animal model of autoimmune disease associated pruritus would contribute to a better understanding of the pathophysiology of this symptom and lead to the development of safe and effective antipruritic agents. We noticed spontaneous scratching behavior in aged MRL/lpr mice, a model of autoimmune disease. This scratching behavior was observed in a specific pathogen-free environment and was more frequent in female mice. In contrast to animal models of dermatitis; NC/Nga mice, the serum IgE and IgG1 levels in MRL/lpr mice were not elevated. These features indicate that this scratching behavior is similar to human autoimmune disease associated pruritus. The antipruritic effects of an antihistamine (chlorpheniramine), an opioid receptor antagonist (naltrexone), and a novel κ-opioid receptor agonist (nalfurafine hydrochloride [TRK-820]) were evaluated. The frequency of scratching was not reduced by oral administration of chlorpheniramine, suggesting that the behavior is antihistamine-resistant. The oral administration of nalfurafine and subcutaneously administered naltrexone inhibited the scratching behavior without causing gross behavioral changes. In conclusion, MRL/lpr mice scratching behavior is a suitable model of pruritus that occurs in autoimmune diseases, and nalfurafine was shown to be efficacious against this behavior suggesting that it may be beneficial in patients with autoimmune disease associated pruritus.

AB - Pruritus is a common, distressing and difficult to manage complication of many autoimmune diseases. A suitable animal model of autoimmune disease associated pruritus would contribute to a better understanding of the pathophysiology of this symptom and lead to the development of safe and effective antipruritic agents. We noticed spontaneous scratching behavior in aged MRL/lpr mice, a model of autoimmune disease. This scratching behavior was observed in a specific pathogen-free environment and was more frequent in female mice. In contrast to animal models of dermatitis; NC/Nga mice, the serum IgE and IgG1 levels in MRL/lpr mice were not elevated. These features indicate that this scratching behavior is similar to human autoimmune disease associated pruritus. The antipruritic effects of an antihistamine (chlorpheniramine), an opioid receptor antagonist (naltrexone), and a novel κ-opioid receptor agonist (nalfurafine hydrochloride [TRK-820]) were evaluated. The frequency of scratching was not reduced by oral administration of chlorpheniramine, suggesting that the behavior is antihistamine-resistant. The oral administration of nalfurafine and subcutaneously administered naltrexone inhibited the scratching behavior without causing gross behavioral changes. In conclusion, MRL/lpr mice scratching behavior is a suitable model of pruritus that occurs in autoimmune diseases, and nalfurafine was shown to be efficacious against this behavior suggesting that it may be beneficial in patients with autoimmune disease associated pruritus.

KW - κ-opioid agonist

KW - MRL/lpr mouse

KW - Pruritus

KW - Scratching behavior

UR - http://www.scopus.com/inward/record.url?scp=23644458759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23644458759&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2005.06.019

DO - 10.1016/j.ejphar.2005.06.019

M3 - Article

C2 - 16055114

AN - SCOPUS:23644458759

VL - 518

SP - 133

EP - 139

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -